Skip to main content

J1939 HCPCS Level II Code: Injection, bumetanide, 0.5 mg

Medicare Coverage & Payment

  • CMS short descriptor: Inj, bumetanide, 0.5 mg
  • Medicare coverage: Special coverage instructions apply (CMS coverage code D)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2025

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Overview

Injection, bumetanide, 0.5 mg is a HCPCS Level II code (J1939). CMS assigns coverage code D — Special coverage instructions apply. Short description: Inj, bumetanide, 0.5 mg.

Summary composed by MedCoder from this code's official HCPCS Level II record. The tabular instructional notes themselves appear verbatim below.

Change history

  • 2024-01-01
    Added to the code set
    Injection, bumetanide, 0.5 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $0.50

00641-6007-10 Bumetanide — Hikma Pharmaceuticals USA Inc. (size 10 × qty 10 (0.5 MG per billing unit))

00641-6008-10 Bumetanide — Hikma Pharmaceuticals USA Inc. (size 4 × qty 10 (0.5 MG per billing unit))

00641-6161-10 Bumetanide — Hikma Pharmaceuticals USA Inc. (size 4 × qty 10 (0.5 MG per billing unit))

00641-6162-10 Bumetanide — Hikma Pharmaceuticals USA Inc. (size 10 × qty 10 (0.5 MG per billing unit))

00641-6284-10 Bumetanide — Hikma Pharmaceuticals USA Inc. (size 4 × qty 10 (0.5 MG per billing unit))

00641-6285-10 Bumetanide — Hikma Pharmaceuticals USA Inc. (size 10 × qty 10 (0.5 MG per billing unit))

25021-0321-04 Bumetanide — Sagent Pharmaceuticals (size 4 × qty 10 (0.5 MG per billing unit))

25021-0321-10 Bumetanide — Sagent Pharmaceuticals (size 10 × qty 10 (0.5 MG per billing unit))

65219-0570-04 Bumetanide — FreseniUS Kabi USA, LLC (size 4 × qty 10 (0.5 MG per billing unit))

65219-0572-10 Bumetanide — FreseniUS Kabi USA, LLC (size 10 × qty 10 (0.5 MG per billing unit))

68462-0469-54 Bumetanide — Glenmark Pharmaceuticals Inc., USA (size 4 × qty 10 (0.5 MG per billing unit))

68462-0470-54 Bumetanide — Glenmark Pharmaceuticals Inc., USA (size 10 × qty 10 (0.5 MG per billing unit))

70748-0323-10 Bumetanide — Lupin Pharmaceuticals, Inc. (size 4 × qty 10 (0.5 MG per billing unit))

70748-0323-11 Bumetanide — Lupin Pharmaceuticals, Inc. (size 10 × qty 10 (0.5 MG per billing unit))

70860-0406-10 Bumetanide — Athenex Pharmaceutical Division, LLC (size 10 × qty 10 (0.5 MG per billing unit))

72205-0101-07 Bumetanide — Novadoz Pharmaceuticals LLC (size 4 × qty 10 (0.5 MG per billing unit))

72205-0102-07 Bumetanide — Novadoz Pharmaceuticals LLC (size 10 × qty 10 (0.5 MG per billing unit))

72572-0040-10 Bumetanide — Civica, Inc. (size 4 × qty 10 (0.5 MG per billing unit))

72572-0041-10 Bumetanide — Civica, Inc. (size 10 × qty 10 (0.5 MG per billing unit))

83301-0080-02 Bumetanide — Mullan Pharmaceutical Inc. (size 4 × qty 10 (0.5 MG per billing unit))

+1 more

Related Codes

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from the CMS ASP crosswalk and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.1X1 — Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), T50.1X2 — Poisoning by loop [high-ceiling] diuretics, intentional self-harm, T50.1X3 — Poisoning by loop [high-ceiling] diuretics, assault, T50.1X4 — Poisoning by loop [high-ceiling] diuretics, undetermined, T50.1X5 — Adverse effect of loop [high-ceiling] diuretics, T50.1X6 — Underdosing of loop [high-ceiling] diuretics

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1939 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (23)

  • J1920 — Injection, labetalol hydrochloride, 5 mg [Sibling]
  • J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg [Sibling]
  • J1930 — Injection, lanreotide, 1 mg [Sibling]
  • J1931 — Injection, laronidase, 0.1 mg [Sibling]
  • J1932 — Injection, lanreotide, (cipla), 1 mg [Sibling]
  • J1938 — Injection, furosemide, 1 mg [Sibling]
  • J1940 — Injection, furosemide, up to 20 mg [Sibling]
  • J1941 — Injection, furosemide (furoscix), 20 mg [Sibling]
  • and 15 more

Change history

  • 2024-01-01 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1939 in its code family, with their registry titles.

  • J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
  • J1930 — Injection, lanreotide, 1 mg
  • J1931 — Injection, laronidase, 0.1 mg
  • J1932 — Injection, lanreotide, (cipla), 1 mg
  • J1938 — Injection, furosemide, 1 mg
  • J1940 — Injection, furosemide, up to 20 mg
  • J1941 — Injection, furosemide (furoscix), 20 mg
  • J1942 — Injection, aripiprazole lauroxil, 1 mg
  • J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
  • J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg